Relationship between deep venous thrombosis and inflammatory cytokines in postoperative patients with malignant abdominal tumors

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 11, 2014, Pages 1003-1007

  Du, T ^a   Tan, Z ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Abdominal surgery; Correlation; Deep venous thrombosis (DVT); Inflammatory cytokine; Malignant tumor

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; AUTACOID;

ABDOMINAL TUMOR; ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ABDOMINAL NEOPLASMS; BLOOD; METABOLISM; MIDDLE AGED; POSTOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOSIS;

ABDOMINAL NEOPLASMS; ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOKINES; E-SELECTIN; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; NF-KAPPA B; POSTOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84923329936     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20143695     Document Type: Article

References (24)

1. Stein PD, Goodman LR, Hull RD, Dalen JE, Matta F. Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options. Clin Appl Thromb Hemost 2012; 18: 20-26, doi:10.1177/1076029611422363.
2. Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Sperati F, et al. Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst Rev 2011; CD006468.
3. Tufano A, Coppola A, Cerbone AM, Ruosi C, Franchini M. Preventing postsurgical venous thromboembolism: pharmacological approaches. Semin Thromb Hemost 2011; 37: 252-266, doi:10.1055/s-0031-1273089.
4. Sood V, Luke CE, Deatrick KB, Baldwin J, Miller EM, Elfline M, et al. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb Haemost 2010; 104: 1174-1183, doi:10.1160/TH10-03-0184.
5. Xenos ES, Vargas HD, Davenport DL. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res 2012; 129: 568-572, doi:10.1016/j.thromres.2011.07.047.
6. van den Berg YW, Versteeg HH. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes? Hamostaseologie 2010; 30: 144-149.
7. Rudolph V, Freeman BA. Cardiovascular consequences when nitric oxide and lipid signaling converge. Circ Res 2009; 105: 511-522, doi:10.1161/CIRCRESAHA.109. 202077.
8. New SE, Aikawa E. Cardiovascular calcification: an inflammatory disease. Circ J 2011; 75: 1305-1313, doi:10.1253/circj.CJ-11-0395.
9. Marik PE, Flemmer M. The immune response to surgery and trauma: Implications for treatment. J Trauma Acute Care Surg 2012; 73: 801-808, doi:10.1097/TA.0b013e318265cf87.
10. Chen W, Li Z, Bai L, Lin Y. NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci 2011; 16: 1172-1185, doi:10.2741/3782.
11. Burton-Freeman B. Postprandial metabolic events and fruit-derived phenolics: a review of the science. Br J Nutr 2010; 104 (Suppl 3): S1-S14, doi:10.1017/S0007114510003909.
12. Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res 2008; 58: 88-111, doi:10.1016/j.phrs.2008.06.007.
13. Kones R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease - a perspective. Drug Des Devel Ther 2010; 4: 383-413, doi:10.2147/DDDT.S10812.
14. Shah R, Burg MM, Vashist A, Collins D, Liu J, Jadbabaie F, et al. C-reactive protein and vulnerability to mental stress-induced myocardial ischemia. Mol Med 2006; 12: 269-274, doi:10.2119/2006-00077.Shah.
15. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006; 440: 1217-1221, doi:10.1038/nature04672.
16. Medzhitov R, Shevach EM, Trinchieri G, Mellor AL, Munn DH, Gordon S, et al. Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol 2011; 11: 693-702, doi:10.1038/nri3063.
17. Obitsu Y, Shigematsu H. [Deep vein thrombosis in patients with cancer]. Gan To Kagaku Ryoho 2009; 36: 535-539.
18. Boon RA, Horrevoets AJ. Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie 2009; 29: 39-43.
19. Proctor MC, Sullivan V, Zajkowski P, Wolk SW, Pomerantz RA, Wakefield TW, et al. A role for interleukin-10 in the assessment of venous thromboembolism risk in injured patients. J Trauma 2006; 60: 147-151, doi:10.1097/01.ta.0000197180.79965.bc.
20. Ben-Hadj-Khalifa S, Nguyen P, Mahjoub T, Hezard N. Anticoagulant properties of the anti-inflammatory cytokine IL-10 in a factor Xa-activated human monocyte model. Eur Cytokine Netw 2012; 23: 87-92.
21. Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Hohne C, et al. Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth 2008; 101: 781-787, doi:10.1093/bja/aen287.
22. Myers D Jr, Farris D, Hawley A, Wrobleski S, Chapman A, Stoolman L, et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002; 108: 212-221, doi:10.1006/jsre.2002.6552.
23. Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009; 53: 317-333, doi:10.1016/j.jjcc.2008.12.007.
24. Yoshida M, Takano Y, Sasaoka T, Izumi T, Kimura A. E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions under flow conditions. Arterioscler Thromb Vasc Biol 2003; 23: 783-788, doi:10.1161/01.ATV.0000067427.40133.59.